Amgen Inc. (AMGN) Q1 2020 Earnings Results

Amgen Beats on EPS, Stock Up 1.5%

Amgen's earnings report shows a solid performance with an EPS beat, which contributed to a 1.5% increase in stock price. The company remains optimistic about product demand, although no specific guidance was given for the future. Investors may view the EPS surprise as a positive indicator of the company's resilience in a challenging environment.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$4.17	N/A	+12.82%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a positive outlook despite current uncertainties. They emphasized the strength of their product portfolio.

Management highlighted ongoing strong demand for key products.

They acknowledged challenges but expressed confidence in long-term growth.

Amgen Beats on EPS, Stock Up 1.5%

Key numbers

Management commentary

Amgen Inc.

More earnings this week

Amgen Beats on EPS, Stock Up 1.5%

Key numbers

Management commentary